PP
HZNP

Prudential plc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Prudential plc’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,742
Closed -$896K – 918
2023
Q3 		$896K Sell
7,742
-1,503
-16% -$161K 0.01% 559
2023
Q2 		$951K Buy
+9,245
New +$975K 0.01% 603
2018
Q3 		– Sell
-444,796
Closed -$7.37M – 783
2018
Q2 		$7.37M Hold
444,796
– – 0.02% 339
2018
Q1 		$6.32M Hold
444,796
– – 0.02% 366
2017
Q4 		$6.49M Buy
444,796
+105,500
+31% +$1.48M 0.02% 371
2017
Q3 		$4.3M Hold
339,296
– – 0.01% 405
2017
Q2 		$4.03M Buy
+339,296
New +$4.22M 0.01% 411

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Prudential plc's HZNP Position: Q4 2023 in Review

Prudential plc sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 7,742 shares — an estimated $896K sold.

Prudential plc first reported a position in HZNP in Q2 2017 and held it in 7 quarters. The position peaked at $7.37M in Q2 2018. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Prudential plc reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Prudential plc sold 7,742 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $896K.
  • Prudential plc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and held it in 7 quarters.
  • Prudential plc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7.37M in Q2 2018.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Prudential plc's 13F filing for Q4 2023, filed 14 Feb 2024.